Daiki Hira

Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation

Satoshi Ueshima, Daiki Hira, Ryo Fujii et al. · Pharmacogenetics and Genomics · 2017 · 83 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Assessment of Sunitinib-Induced Toxicities and Clinical Outcomes Based on Therapeutic Drug Monitoring of Sunitinib for Patients With Renal Cell Carcinoma

Satoshi Noda, Takashi Otsuji, Masato Baba et al. · Clinical Genitourinary Cancer · 2015 · 79 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Gene Silencing in a Mouse Lung Metastasis Model by an Inhalable Dry Small Interfering RNA Powder Prepared Using the Supercritical Carbon Dioxide Technique

Tomoyuki Okuda, Daisuke Kito, Ai Oiwa et al. · Biological and Pharmaceutical Bulletin · 2013 · 60 citations · Full text

Pharmacy, Biotechnology, Pharmaceutics +17

Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation

Satoshi Ueshima, Daiki Hira, Yuuma Kimura et al. · British Journal of Clinical Pharmacology · 2018 · 50 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device

Hiroko Otake, Tomoyuki Okuda, Daiki Hira et al. · Pharmaceutical Research · 2015 · 43 citations

Pharmacy, Pharmaceutics, Pharmacology +17